Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Peptides ; 181: 171296, 2024 Nov.
Article in English | MEDLINE | ID: mdl-39265810

ABSTRACT

Exercise training leads to physiological cardiac hypertrophy and the protective axis of the renin-angiotensin system composed of angiotensin-converting enzyme 2, angiotensin-(1-7), and Mas receptor seems involved in this process. However, the role of the basal activity of the Mas receptor in exercise-induced physiological cardiac hypertrophy is still unclear. We evaluated the effects of the Mas receptor blockade on the left ventricular structure and function of rats submitted to running training. Rats were assigned to 4 groups: sedentary (S), sedentary + A-779 (Mas receptor antagonist, 120 µg/kg/day, i.p.; SA), trained (60-minute treadmill running sessions, five days a week, 8 weeks; T), and trained + A-779 (TA). Systolic blood pressure was higher in sedentary and trained rats treated with A-779 at the end of the experimental period. The A-779 treatment prevented the left ventricular hypertrophy evoked by physical exercise and increased collagen deposition in sedentary and trained rats. Cardiomyocytes from the SA group presented increased length and thickness of the sarcomeres, elongated mitochondria, glycogen deposits, and enlarged cisterns of the sarcoplasmic reticulum. TA group presented a reduced sarcomere thickness and cytoplasm with a degenerative aspect. These findings show that the basal activity of the Mas receptor is essential for the proper turnover of the extracellular matrix in the myocardium and the maintenance of the sarcomeric structure of cardiomyocytes.


Subject(s)
Cardiomegaly , Physical Conditioning, Animal , Proto-Oncogene Mas , Proto-Oncogene Proteins , Rats, Wistar , Receptors, G-Protein-Coupled , Animals , Rats , Male , Receptors, G-Protein-Coupled/metabolism , Receptors, G-Protein-Coupled/antagonists & inhibitors , Proto-Oncogene Proteins/metabolism , Cardiomegaly/metabolism , Cardiomegaly/chemically induced , Cardiomegaly/pathology , Myocytes, Cardiac/metabolism , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/pathology , Blood Pressure/drug effects , Hypertrophy, Left Ventricular/metabolism , Hypertrophy, Left Ventricular/pathology , Peptide Fragments/pharmacology , Peptide Fragments/metabolism , Angiotensin II/analogs & derivatives
SELECTION OF CITATIONS
SEARCH DETAIL